Ionis Pharmaceuticals IONS Ionis Operations — Medical Affairs Expenses

Similar metrics at other companies

IFFHealth & Biosciences — Selling and administrative expenses

$92M+13.6%

IEXHealth & Science Technologies — Other segment expenses

-$61.1M-15.5%

ILMNCore Illumina — Sales & Marketing

$158M-4.2%

IFFHealth & Biosciences — Research and development expenses

$55M+5.8%

BIIBBIIB080 — Research and development expense

$2.5M—

IQVContract Sales & Medical Solutions — Selling, general and administrative expenses

$17M+13.3%

Questions, answered.

What is Ionis Pharmaceuticals's ionis operations — medical affairs expenses?

Ionis Pharmaceuticals (IONS) reported ionis operations — medical affairs expenses of $9.99M in Q1 2026.

How has Ionis Pharmaceuticals's ionis operations — medical affairs expenses changed year-over-year?

Ionis Pharmaceuticals's ionis operations — medical affairs expenses increased by 77.0% year-over-year, from $5.64M to $9.99M.

What is the long-term trend for Ionis Pharmaceuticals's ionis operations — medical affairs expenses?

Over 3 years (2022 to 2025), Ionis Pharmaceuticals's ionis operations — medical affairs expenses has grown at a 26.1% compound annual growth rate (CAGR), from $15.95M to $32.01M.

What does ionis operations — medical affairs expenses mean?

Costs for medical education, scientific communication, and supporting clinical data usage.

How do you interpret ionis operations — medical affairs expenses?

An increase often supports the launch of new products or expanded indications for existing therapies.

How does ionis operations — medical affairs expenses compare across companies?

Comparable to medical affairs or scientific communications spending at peer biotechs.